Sell on Novo Nordisk A/S: slowing growth, downgraded 2025 guidance, rising GLP-1 competition, pricing/patent risks, limited catalysts. Click for this NVO update.

goeasy suffered a 69% stock collapse after a disastrous pre-earnings update revealed higher-than-expected charge-offs and ...

President Trump said US forces bombed military targets on Iran's Kharg Island - considered Iran's "energy lifeline" - but did not hit oil infrastructure.

Price pressures remain top of mind for many firms, fueling the desire to improve profitability through increased business ...

Market leadership shifted modestly this week, with the performance gap between small cap and large cap stocks narrowing. Read ...

Israel strikes on Iran on February 28 and Iran’s subsequent retaliation have pushed the region into its most volatile ...

One Fiserv reset, Clover growth, and a single-digit P/E offering upside despite 2026 headwinds—read the analysis now.

Enterprise Products Partners (EPD) looks attractive amid oil volatility, with strong cash flow, dividend growth, and DDM ...

AI bubble or normal reset? Learn why today’s AI cycle looks grounded in fundamentals, what volatility to expect, and how to ...

A potential U.S. ground invasion in Iran could trigger an 8%-10% S&P 500 correction, with the market already pricing in some ...

Ron Baron’s BAMCO 13F: top holdings (Tesla, MSCI), major stake changes, and growth strategy insights. Read here for more ...

Cohen & Steers Quality Income Realty Fund has dipped 6%, raising its yield to 8.7% & presenting a potential buying ...